tirzepatide for iih Idiopathic Intracranial Hypertension (IIH) in a Patient on Tirzepatide: Cure or Culprit? A Case Report FDA approves tirzepatide, Eli Lilly's
Description
The starting dose is administered for the first 4 weeks, on the same day each week and at the same time
we provide nutritional advice and ongoing support for our patients on their weight loss journeys
GLP-1 Success A better GLP-1 journey starts here Mike -135 LBS *Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
What are you waiting for
Rates may vary based on pharmacy capacity, state regulations, and individual order details
